HilleVax, Inc.
HLVXDelisted Sep 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001888012
HilleVax, Inc. was delisted on Sep 17, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 74 institutions reported holding it in 13F filings for Q2 2025, worth $82.5M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in HilleVax, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- +7 vs. Q4 2022
- Shares held
- 26.4M
- +1.94M (+7.9%) vs. Q4 2022
- Total value
- $436.2M
- +$26.8M (+6.5%) vs. Q4 2022
- New holders
- 11
- 20 more added
- Sold out
- 4
- 17 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HLVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 74 | $82.5M |
| Q1 2025 | 81 | $61.1M |
| Q4 2024 | 76 | $88.7M |
| Q3 2024 | 79 | $73.5M |
| Q2 2024 | 94 | $657.8M |
| Q1 2024 | 81 | $730.0M |
| Q4 2023 | 69 | $678.3M |
| Q3 2023 | 68 | $459.3M |
| Q2 2023 | 54 | $436.6M |
| Q1 2023 | 61 | $436.2M |
| Q4 2022 | 55 | $440.2M |
| Q3 2022 | 51 | $399.9M |
| Q2 2022 | 57 | $253.7M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding HilleVax, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,781,472 | $161.7M | 11.71% | +23,113+0.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,833,690 | $46.8M | 1.04% | +139,589+5.2% | Added |
| Carlyle Group Inc. | 1,838,486 | $30.1M | 0.90% | +1,838,486 | New |
| Ra Capital Management, L.P. | 1,760,019 | $29.1M | 0.66% | 00.0% | Unchanged |
| Braidwell LP | 1,620,216 | $26.8M | 0.88% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,284,550 | $21.2M | 0.01% | +38,409+3.1% | Added |
| T. Rowe Price Investment Management, Inc. | 1,211,492 | $20.0M | 0.01% | +1700.0% | Added |
| BlackRock Inc. | 1,037,847 | $17.2M | 0.00% | +9,374+0.9% | Added |
| StepStone Group LP | 676,569 | $11.2M | 2.08% | +20.0% | Added |
| Samsara BioCapital, LLC | 609,862 | $10.1M | 2.08% | −2000.0% | Reduced |
| Morgan Stanley | 595,474 | $9.84M | 0.00% | −9,839−1.6% | Reduced |
| Qiming U.S. Ventures Management, LLC | 558,923 | $9.24M | 11.18% | 00.0% | Unchanged |
| Vanguard Group Inc | 491,634 | $8.13M | 0.00% | −209,848−29.9% | Reduced |
| Perceptive Advisors LLC | 406,024 | $6.71M | 0.20% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 287,276 | $4.75M | 0.00% | +9,470+3.4% | Added |
| State Street Corp | 273,037 | $4.51M | 0.00% | +12,666+4.9% | Added |
| BVF Inc | 248,579 | $4.11M | 0.15% | 00.0% | Unchanged |
| Northern Trust Corp | 133,015 | $2.20M | 0.00% | −3,957−2.9% | Reduced |
| Ensign Peak Advisors, Inc | 117,746 | $1.95M | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 102,841 | $1.70M | 0.00% | −259−0.3% | Reduced |
| Fred Alger Management, LLC | 87,043 | $1.44M | 0.01% | −20,667−19.2% | Reduced |
| UBS Oconnor LLC | 81,267 | $1.34M | 0.03% | +81,267 | New |
| Bank of New York Mellon Corp | 48,055 | $794.3K | 0.00% | −1,866−3.7% | Reduced |
| Nuveen Asset Management, LLC | 23,902 | $395.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 23,006 | $380.0K | 0.00% | +1,228+5.6% | Added |
| Alps Advisors Inc | 21,973 | $363.2K | 0.00% | −641−2.8% | Reduced |
| Swiss National Bank | 21,200 | $350.4K | 0.00% | −7,000−24.8% | Reduced |
| TD Asset Management Inc | 18,528 | $306.3K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 18,026 | $297.0K | 0.00% | +18,026 | New |
| California State Teachers Retirement System | 15,082 | $249.3K | 0.00% | −2,031−11.9% | Reduced |
| Goldman Sachs Group Inc | 14,965 | $247.4K | 0.00% | −416−2.7% | Reduced |
| JPMorgan Chase & Co | 14,909 | $246.0K | 0.00% | +3,561+31.4% | Added |
| Bank of America Corp | 13,740 | $227.1K | 0.00% | −8,752−38.9% | Reduced |
| New York State Common Retirement Fund | 12,498 | $206.6K | 0.00% | +1,413+12.7% | Added |
| ETF Managers Group, LLC | 10,857 | $179.5K | 0.01% | +10,857 | New |
| Deutsche Bank AG | 10,776 | $178.1K | 0.00% | +3,252+43.2% | Added |
| Susquehanna International Group, LLP | 10,539 | $174.2K | 0.00% | +10,539 | New |
| State of Wisconsin Investment Board | 10,333 | $170.8K | 0.00% | −1,427−12.1% | Reduced |
| Point72 Asset Management, L.P. | 9,804 | $162.1K | 0.00% | +9,804 | New |
| Barclays PLC | 8,868 | $146.6K | 0.00% | +4,180+89.2% | Added |
| MetLife Investment Management | 8,705 | $143.9K | 0.00% | +667+8.3% | Added |
| American International Group, Inc. | 8,425 | $139.3K | 0.00% | +167+2.0% | Added |
| UBS Group AG | 8,018 | $132.5K | 0.00% | +6,326+373.9% | Added |
| Acuta Capital Partners, LLC | 6,664 | $110.2K | 0.09% | +6,664 | New |
| Sandia Investment Management LP | 6,000 | $99.2K | 0.02% | 00.0% | Unchanged |
| Legal & General Group Plc | 5,114 | $84.5K | 0.00% | +297+6.2% | Added |
| Royal Bank of Canada | 3,707 | $61.0K | 0.00% | −1,451−28.1% | Reduced |
| Wells Fargo & Company | 3,121 | $51.6K | 0.00% | +3,121 | New |
| STRS Ohio | 3,000 | $49.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,587 | $43.0K | 0.00% | +943+57.4% | Added |
| Federated Hermes, Inc. | 2,195 | $36.3K | 0.00% | −355−13.9% | Reduced |
| Amalgamated Bank | 1,969 | $33.0K | 0.00% | −96−4.6% | Reduced |
| Russell Investments Group, Ltd. | 1,572 | $26.0K | 0.00% | +1,572 | New |
| Ameritas Investment Partners, Inc. | 972 | $16.1K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 911 | $15.1K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 626 | $10.3K | 0.00% | −193−23.6% | Reduced |
| FMR LLC | 507 | $8.38K | 0.00% | +337+198.2% | Added |
| China Universal Asset Management Co., Ltd. | 452 | $7.47K | 0.00% | +113+33.3% | Added |
| Cubist Systematic Strategies, LLC | 203 | $3.36K | 0.00% | +203 | New |
| Point72 Middle East FZE | 122 | $2.02K | 0.00% | +122 | New |
| Daiwa Securities Group Inc. | 134 | $2.00K | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 0 | $0 | 0.00% | −16,996−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −9,187−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −3,144−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −2,441−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |